Clinical implications of cystic fibrosis transmembrane conductance regulator mutations

Clinics in Chest Medicine

Volumn 19, Issue 3, 1998, Pages 443-458

  Mickle, J E ^a   Cutting, G R ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSMEMBRANE CONDUCTANCE REGULATOR;

CYSTIC FIBROSIS; GENE FREQUENCY; GENE MUTATION; HUMAN; MUTATION RATE; PHENOTYPE; PRIORITY JOURNAL; REVIEW;

EID: 0031718588     PISSN: 02725231     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0272-5231(05)70092-7     Document Type: Article

References (139)

1. D. Abeliovich I.P. Lavon I. Lerer Screening for five mutations detects 97% of cystic fibrosis (CF) chromosomes and predicts a carrier frequency of 1:29 in the Jewish Ashkenazi population Am J Hum Genet 51 1992 951 956
2. M.P. Anderson H.A. Berger D.P. Rich Nucleotide triphosphates are required to open the CFTR chloride channel Cell 67 1991 775 784
3. M.P. Anderson R.J. Gregory S. Thompson Demonstration that CFTR is a chloride channel by alteration of its anion selectivity Science 253 1991 202 205
4. M.P. Anderson D.P. Rich R.J. Gregory Generation of cAMP-activated chloride currents by expression of CFTR Science 251 1991 679 682
5. A. Augarten B. Kerem Y. Yahav Mild cystic fibrosis and normal or borderline sweat test in patients with the 3849+10 kb C→T mutation Lancet 342 1993 25 26
6. J. Bal M. Stuhrmann M. Schloesser A cystic fibrosis patient homozygous for the nonsense mutation R553X J Med Genet 28 1992 715 717
7. C.E. Bear F. Duguay A.L. Naismith C1-channel activity in Xenopus oocytes expressing the cystic fibrosis gene J Biol Chem 266 1991 19142 19145
8. A.L. Beaudet R.G. Perciaccante G.R. Cutting Homozygous nonsense mutation causing cystic fibrosis with uniparental isodisomy Am J Hum Genet 48 1991 1213
9. F. Becq T.J. Jensen X. Chang Phosphatase inhibitors activate normal and defective CFTR chloride channels Proc Natl Acad Sci 91 1994 9160 9164
10. V. Brancolini L. Cremonesi E. Belloni Search for mutations in pancreatic sufficient cystic fibrosis Italian patients: Detection of 90% of molecular defects and identification of three novel mutations Hum Genet 96 1995 312 318
11. C.M. Canessa J. Horisberger B.C. Rossier Epithelial sodium channel related to proteins involved in neurodegeneration Nature 361 1993 467 470
12. T.P. Carroll I. McIntosh M.E. Egan Transmembrane mutations alter the channels characteristics of the cystic fibrosis transmembrane conductance regulator expressed in Xenopus oocytes Cell Physiol Biochem 4 1994 10 18
13. M.R. Carson S.M. Travis M.J. Welsh The two nucleotide-binding domains of cystic fibrosis transmembrane conductance regulator (CFTR) have distinct functions in controlling channel activity J Biol Chem 270 1995 1711 1717
14. T. Casals P. Pacheco C. Barreto Missense mutation R1066C in the second transmembrane domain of CFTR causes a severe cystic fibrosis phenotype: Study of 19 heterozygous and 2 homozygous patients Hum Mutat 10 1997 387 392
15. −channel activity compensates for defective processing in a mild form of the disease EMBO J 14 1995 2417 2423
16. S.H. Cheng D.P. Rich J. Marshall Phosphorylation of the R domain by cAMP-dependent protein kinase regulates the CFTR chloride channel Cell 66 1991 1027 1036
17. M. Chillón T. Casals B. Mercier Mutations in the cystic fibrosis gene in patients with congenital absence of the vas deferens N Engl J Med 332 1995 1475 1480
18. C. Chu B.C. Trapnell S. Curristin Genetic basis of variable exon 9 skipping in cystic fibrosis transmembrane conductance regulator mRNA Nature Genet 3 1993 151 156
19. C. Chu B.C. Trapnell S.M. Curristin Extensive post-translational deletion of the coding sequences for part of nucleotide-binding fold 1 in respiratory epithelial mRNA transcripts of the cystic fibrosis transmembrane conductance regulator gene is not associated with the clinical manifestations of cystic fibrosis J Clin Invest 90 1992 785 790
20. C. Chu B.C. Trapnell J.J. Murtagh Variable deletion of exon 9 coding sequences in cystic fibrosis transmembrane conductance regulator gene mRNA transcripts in normal bronchial epithelium EMBO J 10 1991 1355 1363
21. M. Claustres L. Maguelone M. Desgeorges Analysis of the 27 exons and flanking regions of the cystic fibrosis gene: 40 different mutations account for 91.2% of the mutant alleles in Southern France Hum Mol Genet 2 1993 1209 1213
22. A.A. Colin S.M. Sawyer J.E. Mickle Pulmonary function and clinical observations in men with congenital bilateral absence of the vas deferens Chest 110 1996 440 445
23. F.S. Collins Cystic fibrosis: Molecular biology and therapeutic implications Science 256 1992 774 779
24. M. Corey P. Durie D. Moore Familial concordance of pancreatic function in cystic fibrosis J Pediatr 115 1989 274 277
25. R.G. Crystal Transfer of genes to humans: Early lessons and obstacles to success Science 270 1995 404 410
26. G.R. Cutting Cystic Fibrosis D.L. Rimoin J.M. Connor R.D. Pyeritz Emery and Rimoin's Principals and Practice of Medical Genetics 1997 Churchill-Livingston London 2685
27. G.R. Cutting S.M. Curristin E. Nash Analysis of four diverse population groups indicates that a subset of cystic fibrosis mutations occur in common among Caucasians Am J Hum Genet 50 1992 1185 1194
28. G.R. Cutting L.M. Kasch B.J. Rosenstein A cluster of cystic fibrosis mutations in the first nucleotide binding domain of the CFTR protein Nature 346 1990 366 369
29. Cystic Fibrosis Genotype/Phenotype Consortium Correlation between genotype and phenotype in cystic fibrosis N Engl J Med 329 1993 1308 1313
30. M. Dean M.B. White J. Amos Multiple mutations in highly conserved residues are found in mildly affected cystic fibrosis patients Cell 61 1990 863 870
31. S.J. Delaney B.J. Wainwright New pharmaceutical approaches to the treatment of cystic fibrosis Nature Med 2 1996 392 393
32. G.M. Denning M.P. Anderson J.F. Amara Processing of mutant cystic fibrosis transmembrane conductance regulator is temperature-sensitive Nature 358 1992 761 764
33. M. Desgeorges M. Rodier M. Piot Four adult patients with the missense mutation L206W and a mild cystic fibrosis phenotype Hum Genet 96 1995 717 720
34. T. Dörk B. Dworniczak C. Aulehla-Scholz Distinct spectrum of CFTR gene mutations in congenital absence of vas deferens Hum Genet 100 1997 365 377
35. T. Dörk M. Stuhrman Severity of disease in cystic fibrosis Lancet 346 1995 1036 1037
36. T. Dörk T. Neümann U. Wulfbrand Intra- and extragenic marker haplotypes of CFTR mutations in cystic fibrosis Hum Genet 88 1992 417 425
37. T. Dörk U. Wulbrand T. Richter Cystic fibrosis with three mutations in the cystic fibrosis transmembrane conductance regulator gene Hum Genet 87 1991 441 446
38. D.H. Dreyfus R. Bethel E.W. Gelfand Cystic fibrosis 3849+10Kb C→T mutation associated with severe pulmonary disease and male fertility Am J Respir Crit Care Med 153 1996 858 860
39. M.L. Drumm D.J. Wilkinson L.S. Smit Chloride conductance expressed by deltaF508 and other mutant CFTRs in Xenopus oocytes Science 254 1991 1797 1799
40. A. Duarte M. Amaral C. Barreto Complex cystic fibrosis allele R344W-R1158X results in reduced levels of correctly processed mRNA in a pancreatic sufficient patient Hum Mutat 8 1996 134 139
41. V. Dumur R. Gervais J.-M. Rigot Congenital bilateral absence of the vas deferens (CBAVD) and cystic fibrosis transmembrane regulator (CFTR): Correlation between genotype and phenotype Hum Genet 97 1996 7 10
42. I. Durieu F. Bey-Omar J. Rollet Diagnostic criteria for cystic fibrosis in men with congenital absence of the vas deferens Medicine 74 1995 42 47
43. −channels by protein kinase A corrected by insertion of CFTR [see comments] Nature 358 1992 581 584
44. H. Eiberg J. Mohr K. Schmiegelow Linkage relationships of paraoxonase (PON) with other markers: Indication of PON-cystic fibrosis synteny Clin Genet 28 1985 265 271
45. X. Estivill C. Bancells C. Ramos Geographic distribution and regional origin of 272 cystic fibrosis mutations in European populations Hum Mutat 10 1997 135 154
46. X. Estivill N. Morral J. Bertranpetit Age of the ΔF508 cystic fibrosis mutation [reply] Nature Genet 8 1994 216 218
47. X. Estivill L. Ortigosa J. Peréz-Frias Clinical characteristics of 16 cystic fibrosis patients with the missense mutation R334W, a pancreatic insufficiency mutation with variable age of onset and interfamilial clinical differences Hum Genet 95 1995 331 336
48. C. Férec M.P. Audrézet B. Mercier Detection of over 98% cystic fibrosis mutations in a Celtic population Nature Genet 1 1992 188 191
49. S.C. Fitzsimmons Cystic Fibrosis Foundation, Patient Registry 1996 Annual Report 1997 Cystic Fibrosis Foundation Bethesda, MD 18
50. K. Friedman H. Teichtahl D.M. DeKretsien Screening Young syndrome patients for CFTR mutations Am J Respir Crit Care Med 152 1995 1353 1357
51. T.M. Fujiwara K. Morgan R.H. Schwartz Genealogical analysis of cystic fibrosis families and chromosome 7q RFLP haplotypes in the Hutterite Brethren Am J Hum Genet 44 1989 327 337
52. S.B. Fulmer E.M. Schwiebert M.M. Morales Two cystic fibrosis transmembrane conductance regulator mutations have different effects on both pulmonary phenotype and regulation of outwardly rectified chloride currents Proc Natl Acad Sci U S A 92 1995 6832 6836
53. K. Gan H.J. Veeze A.M.W. van den Ouweland A cystic fibrosis mutation associated with mild lung disease N Engl J Med 333 1995 95 99
54. E. Alton A mild variant of cystic fibrosis Thorax 51 suppl 2 1996 S51 S54
55. K.H. Gan H.G.M. Heijerman W. Bakker Correlation between genotype and phenotype in patients with cystic fibrosis [letter] N Engl J Med 330 1994 865 866
56. R. Gervais V. Dumur B. Letombe Hypofertility with thick cervical mucus: Another mild form of cystic fibrosis? JAMA 276 1996 1638
57. R.J. Gregory D.P. Rich S.H. Cheng Maturation and function of cystic fibrosis transmembrane conductance regulator variants bearing mutations in putative nucleotide-binding domains 1 and 2 Mol Cell Biol 11 1991 3886 3893
58. H. Guillermit P. Fanen C. Férec A 3′ splice site consensus sequence mutation in the cystic fibrosis gene Hum Genet 85 1990 450 453
59. A. Hamosh S.C. Fitzsimmons M.J. Macek Comparison of the clinical manifestations of cystic fibrosis in African-Americans and Caucasians J Pediatr 132 1998 255 259
60. D.J. Handelsman A.J. Conway L.M. Boylan Young's syndrome. Obstructive azoospermia and chronic sinopulmonary infections N Engl J Med 310 1984 3 9
61. M. Hergershey J. Balakrishnan T. Bettecken A new mutation, 3905insT, accounts for 4.8% of 1173 Cf chromosomes on Switzerland and causes a severe phenotype Hum Genet 100 1997 220 223
62. W.E. Highsmith Jr L.H. Burch Z. Zhou A novel mutation in the cystic fibrosis gene in patients with pulmonary disease but normal sweat chloride concentrations N Engl J Med 331 1994 974 980
63. M. Howard R.A. Frizzell D.M. Bedwell Aminoglycoside antibiotics restore CFTR function by overcoming premature stop mutations Nature Med 2 1996 467 469
64. K. Jarvi J. Zielenski M. Wilschanski Cystic fibrosis transmembrane conductance regulator and obstructive azoospermia Lancet 345 1995 1578
65. N. Kartner O. Augustinas T.J. Jensen Mislocalization of deltaF508 CFTR in cystic fibrosis sweat gland Nature Genet 1 1992 321 327
66. N. Kartner J.W. Hanrahan T.J. Jensen Expression of the cystic fibrosis gene in non-epithelial invertebrate cells produces a regulated anion conductance Cell 64 1991 681 691
67. B. Kerem J.M. Rommens J.A. Buchanan Identification of the cystic fibrosis gene: Genetic analysis Science 245 1989 1073 1080
68. B. Kerem J. Zielenski D. Markiewicz Identification of mutations in regions corresponding to the 2 putative nucleotide (ATP)-binding folds of the cystic fibrosis gene Proc Natl Acad Sci U S A 87 1990 8447 8451
69. E. Kerem M. Corey B. Kerem Clinical and genetic comparisons of patients with cystic fibrosis, with or without meconium ileus J Pediatr 114 1989 767 773
70. E. Kerem M. Corey B. Kerem The relation between genotype and phenotype in cystic fibrosis—analysis of the most common mutation (deltaF508) N Engl J Med 323 1990 1517 1522
71. E. Kerem B. Kerem Genotype-phenotype correlations in cystic fibrosis Pediatr Pulmonol 22 1996 387 395
72. S. Kiesewetter M. Macek Jr C. Davis A mutation in the cystic fibrosis transmembrane conductance regulator gene produces different phenotypes depending on chromosomal background Nat Genet 5 1993 274 278
73. M.R. Knowles N.L. Church W.E. Waltner A pilot study of aerosolized amiloride for the treatment of lung disease in cystic fibrosis N Engl J Med 322 1990 1189 1194
74. Y.H. Ko P.J. Thomas M.R. Delannoy The cystic fibrosis transmembrane conductance regulator J Biol Chem 268 1993 24330 24338
75. M.R. Kosorok W.-H. Wei P.M. Farrell The incidence of cystic fibrosis Stat Med 15 1996 449 462
76. T. Kovesi M. Corey H. Levinson Passive smoking and lung function in cystic fibrosis Am Rev Respir Dis 148 1993 1266 1271
77. P. Kristidis D. Bozon M. Corey Genetic determination of exocrine pancreatic function in cystic fibrosis Am J Hum Genet 50 1992 1178 1184
78. D. Le Lannou P. Jezequel M. Blayau Obstructive azoospermia with agensis of vas deferens or with bronchiectasia (Young's syndrome): A genetic approach Hum Reprod 10 1995 338 341
79. S. Liechti-Gallati R. Kraemer Cystic fibrosis mutations and immotile cilia syndrome Clin Genet 47 1995 328 329
80. G. Lucotte S. Hazout M. De Braekeleer Complete map of cystic fibrosis mutation ΔF508 frequencies in Western Europe and correlation between mutation frequencies and incidence of disease Hum Biol 67 1995 797 803
81. M. Macek Jr A. Macková A. Hamosh Identification of common CF mutations in African-Americans with cystic fibrosis increases the detection rate to 75% Am J Hum Genet 60 1997 1122 1127
82. B. Mercier W. Lissens G. Novelli Identification of eight novel mutations in a collaborative analysis of a part of the second transmembrane domain of the CFTR gene Genomics 16 1993 296 297
83. B. Mercier O. Raguénès X. Estivill Complete detection of mutations in cystic fibrosis patients of Native American origin Hum Genet 94 1994 629 632
84. B. Mercier C. Verlingue W. Lissens Is congenital bilatral absence of vas deferens a primary form of cystic fibrosis? Analyses of the CFTR gene in 67 patients Am J Med Genet 56 1995 272 277
85. J. Mickle A. Milunsky J.A. Amos Congenital unilateral absence of the vas deferens: A heterogeneous disorder with two distinct subpopulations based upon aetiology and mutational status of the cystic fibrosis gene Hum Reprod 10 1995 1728 1735
86. P.W. Miller A. Hamosh M. Macek Jr Cystic fibrosis transmembrane conductance regulator (CFTR) gene mutations inallergic bronchopulmonary aspergillosis Am J Hum Genet 59 1996 45 51
87. N. Morral J. Bertranpetit X. Estivill The origin of the major cystic fibrosis mutation (deltaF508) in European populations Nat Genet 7 1994 169 175
88. N. Morral R. Llevadot T. Casals Independent origins of cystic fibrosis mutations R334W, R347P, R1162X, and 3849+10kbC→T provide evidence of mutation recurrence in the CFTR gene Am J Hum Genet 55 1994 890 898
89. N. Morral V. Nunes T. Casals CA/GT microsatellite alleles within the cystic fibrosis transmembrane conductance regulator (CFTR) gene are not generated by unequal crossingover Genomics 10 1991 692 698
90. P.G. Noone Modulation of the ionic milieu of the airway in health and disease Ann Rev Med 45 1994 421 434
91. L. Osborne G. Santis M. Schwarz Incidence and expression of the N1303K mutation of the cystic fibrosis (CFTR) gene Hum Genet 89 1992 653 658
92. M.R. Picciotto J.A. Cohn G. Bertuzzi Phosphorylation of the cystic fibrosis transmembrane conductance regulator J Biol Chem 267 1992 12742 12752
93. N. Rave-Harel I. Madgar R. Goshen CFTR haplotype analysis reveals genetic heterogeneity in the etiology of congenital bilateral aplasia of the vas deferens Am J Hum Genet 56 1995 1359 1366
94. J. Reiss D.N. Cooper J. Bal Discrimination between recurrent mutation and identity by descent: Application to point mutations in exon 11 of the CFTR gene Hum Genet 87 1991 457 461
95. D.P. Rich M.P. Anderson R.J. Gregory Expression of cystic fibrosis transmembrane conductance regulator corrects defective chloride channel regulation in cystic fibrosis airway epithelial cells Nature 347 1990 358 363
96. D.P. Rich H.A. Berger S.H. Cheng Regulation of the cystic fibrosis transmembrane conductance regulator Cl− channel by negative charge in the R domain J Biol Chem 268 1993 20259 20267
97. J.R. Riordan J.M. Rommens B. Kerem Identification of the cystic fibrosis gene: Cloning and characterization of complementary DNA Science 245 1989 1066 1073
98. J.M. Rommens M.C. Iannuzzi B. Kerem Identification of the cystic fibrosis gene: Chromosome walking and jumping Science 245 1989 1059 1065
99. R. Rozen L. Ferreira-Rajabi L. Robb L206W mutation of the cystic fibrosis gene, relatively frequent in French Canadians, is associated with atypical presentations of cystic fibrosis Am J Med Genet 57 1995 437 439
100. R. Rozen R.H. Schwartz B.C. Hilman Cystic fibrosis mutations in North American populations of French ancestry: Analysis of Quebec French-Canadian and Louisiana Acadian families Am J Hum Genet 47 1990 606 610
101. R. Rozmahel M. Wilschanski A. Matin Modulation of disease severity in cystic fibrosis transmembrane conductance regulator deficient mice by a secondary genetic factor Nature Genet 12 1996 280 287
102. G. Santis L. Osborne R. Knight Genotype-phenotype relationship in cystic fibrosis: Results from the study of monozygotic and dizygotic twins with cystic fibrosis Pediatr Pulmonol Suppl 8 1992 239 240
103. G. Santis L. Osborne R.A. Knight Independent genetic determinants of pancreatic and pulmonary status in cystic fibrosis Lancet 336 1990 1081 1084
104. S. Sato C.L. Ward M.E. Krouse Glycerol reverses the misfolding phenotype of the most common cystic fibrosis mutation J Biol Chem 271 1996 635 638
105. A. Savov D. Angelicheva A. Balassopoulou Double mutant alleles: Are they rare? Hum Mol Genet 4 1995 1169 1171
106. M. Schloesser S. Arleth U. Lenz A cystic fibrosis patient with the nonsense mutation G542X and the splice site mutation 1717-1 J Med Genet 28 1991 878 880
107. E.M. Schwiebert M.E. Egan T. Hwang CFTR regulates outwardly rectifying chloride channels through an autocrine mechanism involving ATP Cell 81 1995 1 20
108. E.M. Schwiebert T.R. Flotte G.R. Cutting Both CFTR and outwardly rectifying chloride channels contribute to cAMP-stimulated whole cell chloride currents Am J Physiol (Cell) 266 1994 C1464 C1477
109. F.S. Seibert P. Linsdell T.W. Loo Disease-associated mutations in the fourth cytoplasmic loop of cystic fibrosis transmembrane conductance regulator compromise biosynthetic processing and chloride channel activity J Biol Chem 271 1996 15139 15145
110. J.L. Serre B. Bouy-Simon E. Mornet Studies of RFLP closely linked to the cystic fibrosis locus throughout Europe lead to new considerations in populations genetics Hum Genet 84 1990 449 454
111. D.N. Sheppard L.S. Ostedgaard M.C. Winter Mechanism of dysfunction of two nucleotide binding domain mutations in cystic fibrosis transmembrane conductance regulator that are associated with pancreatic sufficiency EMBO J 14 1995 876 883
112. −channels with altered pore properties Nature 362 1993 160 164
113. L.S. Smit D.J. Wilkinson M.K. Mansoura Functional roles of the nucleotide-binding folds in the activation of the cystic fibrosis transmembrane conductance regulator Proc Natl Acad Sci U S A 90 1993 9963 9967
114. J.J. Smith S.M. Travis P. Greenberg Cystic fibrosis airway epithelia fail to kill bacteria because of abnormal airway surface fluid Cell 85 1996 229 236
115. R.C. Stern T.F. Boat C.F. Doershuk Obstructive azoospermia as a diagnostic criterion for the cystic fibrosis syndrome Lancet 1 1982 1401 1404
116. R.C. Stern C.F. Doershuk M.L. Drumm 3849+10 kb C→T mutation and disease severity in cystic fibrosis Lancet 346 1995 274 276
117. T.V. Strong L.S. Smit S.V. Turpin Cystic fibrosis gene mutation in two sisters with mild disease and normal sweat electrolyte levels N Engl J Med 325 1991 1630 1634
118. M.J. Stutts C.M. Canessa J.C. Olsen CFTR as a cAMP-dependent regulator of sodium channels Science 269 1995 847 850
119. M. Super Cystic fibrosis in the South West African Afrikaner South Afr Med J 49 1975 818 820
120. J.A. Tabcharani X. Chang J.R. Riordan Phosphorylation-regulated Cl channel in CHO cells stably expressing the cystic fibrosis gene Nature 352 1991 628 631
121. J.A. Tabcharani J.M. Rommens Y. Hou Multi-ion pore behavior in the CFTR chloride channel Nature 366 1993 79 82
122. J.L. Teem H.A. Berger L.S. Ostedgaard Identification of revertants for the cystic fibrosis delta F508 mutation using STE6-CFTR chimeras in yeast Cell 73 1993 335 346
123. P.J. Thomas P. Shenbagamurthi X. Ysern Cystic fibrosis transmembrane conductance regulator: Nucleotide binding to a synthetic peptide Science 251 1991 555 557
124. S.M. Travis M.R. Carson D.R. Ries Interaction of nucleotides with membrane-associated with cystic fibrosis transmembrane conductance regulator J Biol Chem 268 1993 15336 15339
125. L. Tsui The spectrum of cystic fibrosis mutations Trends Genet 8 1992 392 398
126. L. Tsui M. Buchwald D. Barker Cystic fibrosis locus defined by a genetically linked polymorphic DNA marker Science 239 1985 1054 1057
127. L.-C. Tsui P. Durie Genotype and phenotype in cystic fibrosis Hosp Pract (Off Ed) 32 1997 115 142
128. M. Vidaud P. Fanen J. Martin Three point mutations in the CFTR gene in French cystic fibrosis patients: Identification by denaturing gradient gel electrophoresis Hum Genet 85 1990 446 449
129. B.J. Wainwright P.J. Scambler J. Schmidtke Localization of cystic fibrosis locus to human chromosome 7cen-q22 Nature 318 1985 384 385
130. M.J. Welsh A.E. Smith Molecular mechanisms of CFTR chloride channel dysfunction in cystic fibrosis Cell 73 1993 1251 1254
131. M.J. Welsh L. Tsui T.F. Boat Cystic Fibrosis C.R. Scriver A.L. Beaudet W.S. Sly The Metabolic and Molecular Bases of Inherited Disease ed 7 1995 McGraw-Hill New York 3799
132. R. White S. Woodward M. Leppert A closely linked genetic marker for cystic fibrosis Nature 318 1985 382 384
133. J.A. Wood A.P. Fishman K. Reemtsma A comparison of sweat chlorides and intestinal fat absorption in chronic emphysema and fibrocystic disease of the pancreas N Engl J Med 260 1959 951 957
134. H. Zar L. Saiman L. Quittell Binding of Pseudomonas aeruginosa to respiratory epithelial cells from patients with various mutations in the cystic fibrosis transmembrane regulator J Pediatr 126 1995 230 233
135. J. Zielenski T.M. Fujiwara D. Markiewicz Identification of the M1101K mutation in the cystic fibrosis transmembrane conductance regulator (CFTR) gene and complete detection of cystic fibrosis mutations in the hutterite population Am J Med Genet 52 1993 609 615
136. J. Zielenski D. Markiewicz F. Rininsland A cluster of highly polymorphic dinucleotide repeats in intron 17b of the cystic fibrosis transmembrane conductance regulator (CFTR) gene Am J Med Genet 49 1991 1256 1262
137. J. Zielenski P. Patrizio M. Corey CFTR gene variant for patients with congenital absence of vas deferens Am J Hum Genet 57 1995 958 960
138. J. Zielenski R. Rozmahel D. Bozon Genomic DNA sequence of the cystic fibrosis transmembrane conductance regulator (CFTR) gene Genomics 10 1991 214 228
139. J. Zielenski L.-C. Tsiu Cystic fibrosis: Genotypic and phenotypic variations Annu Rev Genet 29 1995 777 807